NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/02/2023
Back to search
Official data from USPTO
CELIXSYS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
11/05/2023
Trademark type
Word
Nice classes
40
Filing date
02/14/2008
Registration date
05/01/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/02/2023
Last transaction
11/05/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/11/2007
First use in commerce
03/18/2008
Drawing code
4
Owner type
03
Owner location
Chiba, JP
Examiner
KEATING, MICHAEL
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Bio Matrix Research Inc.
Representatives
Melissa S. Dillenbeck Faegre Drinker Biddle & Reath LLP
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Manufacturing services for others in the field of pharmaceuticals and chemicals
Publications
History of USPTO decisions and trademark events.
42 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/02/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/02/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/24/2023
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/25/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/11/2023
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
11/03/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/12/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
04/14/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/01/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/15/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/15/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/14/2018
E815
TEAS SECTION 8 & 15 RECEIVED
03/01/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/01/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/24/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/23/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/22/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/22/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/21/2012
IUAF
USE AMENDMENT FILED
02/24/2012
EISU
TEAS STATEMENT OF USE RECEIVED
02/24/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/26/2011
EX1G
SOU EXTENSION 1 GRANTED
08/24/2011
EXT1
SOU EXTENSION 1 FILED
08/24/2011
EEXT
SOU TEAS EXTENSION RECEIVED
08/24/2011
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/08/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/11/2011
PUBO
PUBLISHED FOR OPPOSITION
01/11/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/03/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2010
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/01/2010
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/01/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/01/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/01/2008
ALIE
ASSIGNED TO LIE
12/01/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/28/2008
GNSL
LETTER OF SUSPENSION E-MAILED
05/28/2008
CNSL
SUSPENSION LETTER WRITTEN
05/28/2008
DOCK
ASSIGNED TO EXAMINER
05/27/2008
NWAP
NEW APPLICATION ENTERED
02/20/2008
Continuous trademark protection
Get notified about every new filing that threatens CELIXSYS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.